Back to MW MARSHALL WACE, LLP

PRLDPRLD
14 quarters

Position history for MWMARSHALL WACE, LLP's holdings in PRELUDE THERAPEUTICS INC

MARSHALL WACE, LLP holds 190,692 shares of PRLD (PRELUDE THERAPEUTICS INC), worth $1M as of 2026-Q2. The position was decreased (-46.9% shares). PRLD represents 0.0% of MARSHALL WACE, LLP's portfolio.

Current Value

$1M

Current Shares

190,692

Total Value Change

-$253,613

Total Shares Change

+161,377

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
190,692
-46.9%
$1M0.0%$5.33
0
2026-Q1
Increased
358,906
+31.0%
$1.2M0.0%$2.63
32
2025-Q4
New
273,883
-
$794,2600.0%$2.84
34
2025-Q3
Exited
0
-100.0%
$00.0%$1.37
0
2025-Q2
New
41,747
-
$33,8150.0%$0.79
30
2025-Q1
Exited
0
-100.0%
$00.0%$0.80
0
2024-Q4
Increased
392,155
+9.2%
$498,0380.0%$1.21
26
2024-Q3
New
359,137
-
$743,4140.0%$2.12
34
2022-Q3
Exited
0
-100.0%
$00.0%$6.52
0
2022-Q2
Decreased
45,716
-59.1%
$238,0000.0%$5.18
0
2022-Q1
Decreased
111,777
-58.3%
$772,0000.0%$6.96
0
2021-Q4
New
268,018
-
$3.3M0.0%$12.76
37
2021-Q2
Exited
0
-100.0%
$00.0%$30.02
0
2021-Q1
New
29,315
-
$1.3M0.0%$39.27
35

Other major holders of PRLD: BAKER BROS. ADVISORS LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used